Abstract-Mitochondria are an important source of reactive oxygen species (ROS), implicated in ischemia/reperfusion injury. When isolated from ischemic myocardium, mitochondria demonstrate increased ROS production as a result of damage to electron transport complexes. To investigate the mechanisms, we studied effects of hypoxia/reoxygenation on ROS production by isolated energized heart mitochondria. ROS production, tracked using Fe 2ϩ -catalyzed, H 2 O 2 -dependent H 2 DCF oxidation or Amplex Red, was similar during normoxia and hypoxia but markedly increased during reoxygenation, in proportion to the duration of hypoxia. In contrast, if mitochondria were rapidly converted from normoxia to near-anoxia ([O 2 ], Ͻ1 mol/L), the increase in H 2 DCF oxidation rate during reoxygenation was markedly blunted. To elicit the robust increase in H 2 DCF oxidation rate during reoxygenation, hypoxia had to be severe enough to cause partial, but not complete, respiratory chain inhibition (as shown by partial dissipation of membrane potential and increased NADH autofluorescence). Consistent with its cardioprotective actions, nitric oxide (Ṅ O) abrogated increased H 2 DCF oxidation under these conditions, as well as attenuating ROS-induced increases in matrix [Fe 2ϩ ] and aconitase inhibition caused by antimycin. Collectively, these results suggest that (1) hypoxia that is sufficient to cause partial respiratory inhibition is more damaging to mitochondria than near-anoxia; and (2) Key Words: mitochondria Ⅲ reactive oxygen species Ⅲ hypoxia/reoxygenation Ⅲ nitric oxide R eactive oxygen species (ROS) generated during prolonged ischemia and subsequent reperfusion are known to contribute to ischemia/reperfusion injury (reviewed elsewhere 1 ), although, paradoxically, transient ROS generation is also an essential trigger for cardioprotection by ischemic (IP) and pharmacological preconditioning (reviewed elsewhere 2 ). In cardiac cells, mitochondria are the major source of ROS, although intracellular NADPH oxidase, xanthine oxidase, monoamine oxidase, etc, may become important ROS sources under pathophysiological conditions. Mitochondria energized with physiologically relevant NADH-related substrates produce very little ROS, unless other factors, such as respiratory chain inhibitors (reviewed elsewhere 3 ) or mitochondrial ATP-sensitive K channel activators, 4 are also present. Experiments with isolated cardiac myocytes have demonstrated that hypoxia increases ROS production and implicate mitochondria as the major source. 5, 6 ROS are known to damage electron transport complexes, 7 potentially leading to a positive-feedback cycle during ischemia/reperfusion or hypoxia/reoxygenation, in which increased ROS toxicity impairs respiration, leading to further increases in ROS production, further respiratory dysfunction, and so forth. If this hypothesis is correct, then anoxia should be less effective in supporting this positivefeedback cycle, because ROS production requires the presence of some O 2 . To test the importance of hypoxia versus near-anoxia on ROS production, we compared ROS production by isolated energized cardiac mitochondria exposed to graded levels of hypoxia, followed by reoxygenation. We find that ROS production, measured from Fe 2ϩ -dependent H 2 DCF oxidation rate, is markedly increased after reoxygenation preceded by hypoxia, but not near-anoxia
R eactive oxygen species (ROS) generated during prolonged ischemia and subsequent reperfusion are known to contribute to ischemia/reperfusion injury (reviewed elsewhere 1 ), although, paradoxically, transient ROS generation is also an essential trigger for cardioprotection by ischemic (IP) and pharmacological preconditioning (reviewed elsewhere 2 ). In cardiac cells, mitochondria are the major source of ROS, although intracellular NADPH oxidase, xanthine oxidase, monoamine oxidase, etc, may become important ROS sources under pathophysiological conditions. Mitochondria energized with physiologically relevant NADH-related substrates produce very little ROS, unless other factors, such as respiratory chain inhibitors (reviewed elsewhere 3 ) or mitochondrial ATP-sensitive K channel activators, 4 are also present. Experiments with isolated cardiac myocytes have demonstrated that hypoxia increases ROS production and implicate mitochondria as the major source. 5, 6 ROS are known to damage electron transport complexes, 7 potentially leading to a positive-feedback cycle during ischemia/reperfusion or hypoxia/reoxygenation, in which increased ROS toxicity impairs respiration, leading to further increases in ROS production, further respiratory dysfunction, and so forth. If this hypothesis is correct, then anoxia should be less effective in supporting this positivefeedback cycle, because ROS production requires the presence of some O 2 . To test the importance of hypoxia versus near-anoxia on ROS production, we compared ROS production by isolated energized cardiac mitochondria exposed to graded levels of hypoxia, followed by reoxygenation. We find that ROS production, measured from Fe 2ϩ -dependent H 2 DCF oxidation rate, is markedly increased after reoxygenation preceded by hypoxia, but not near-anoxia ([O 2 ], Ͻ1 mol/L).
A second goal of this study was to test how nitric oxide (Ṅ O) impacts hypoxia-induced ROS production, because Ṅ O plays an important role in redox-based cell signaling and is cardioprotective against ischemia/reperfusion injury. 8 Both ROS and Ṅ O interact with thiol groups, and Ṅ O also binds Fe 2ϩ with high affinity, preventing its participation in hydroxyl radical formation from H 2 O 2 by the Fenton reaction. Consistent with this idea, we find that Ṅ O markedly suppresses reoxygenation-induced H 2 DCF oxidation, ROS-induced matrix Fe 2ϩ increase, and aconitase inactivation, which may contribute to its cardioprotective actions.
Materials and Methods
This study was conducted in accordance with the Guide for the Care and Use of Laboratory Animals (National Academic Press, Washington DC, 1996). All procedures were approved by UCLA Animal Research Committee. All measurements were carried out using a Fiber Optic Spectrofluorometer (Ocean Optics) in a partially open continuously stirred cuvette at room temperature (22 to 24°C). Mitochondria were isolated from rabbit hearts as described previously 9 and added (0.5 to 1.0 mg/mL) to incubation buffer containing 100 mmol/L KCl, 10 mmol/L Hepes, pH 7.4 with Tris, followed by addition of 2.5 mmol/L potassium phosphate (P i ) and substrates as indicated. In some experiments, ADP was added in combination with hexokinase, glucose, and MgCl 2 to ensure a continuous ADP load to mitochondria, similarly to that in active cardiac cells.
O 2 delivery was regulated by adjusting stirring speed (settings 1 to 10, corresponding to 60 to 1100 rpm). The effect of stirring speed on the rate of O 2 diffusion into buffer, and how this was balanced by O 2 consumption by respiring mitochondria to regulate buffer [O 2 ] levels, is shown in the online data supplement, available at http://circres. ahajournals.org. Alternatively, O 2 delivery could be increased rapidly and significantly by injecting a small amount of compressed air into the buffer.
Mitochondria O 2 consumption was measured continuously by monitoring buffer O 2 content via a fiber optic oxygen sensor FOXY-AL300 (Ocean Optics). The O 2 sensor responded to O 2 changes at the level of Ͼ1 mol/L (ϭ0.1 kPaϭ0.75 mm Hg) (see the online data supplement).
Mitochondrial membrane potential (⌬ m ) was estimated using tetramethylrhodamine methyl ester (TMRM) (200 nmol/L) in the buffer solution. 9 ROS production was monitored from reduced dichlorofluorescin (H 2 DCF) oxidation (excitation/emission, 490/525 nm) after incubating mitochondria with H 2 DCF diacetate (10 mol/L) and washing away extramitochondrial dye. Alternatively, O 2 . production was measured using MitoSOX red (excitation/emission, 510/580 nm). 10 H 2 O 2 release from mitochondria was measured using Amplex Red Hydrogen Peroxide Assay Kit (Invitrogen) (excitation/emission, 560/590 nm) (see Figure IV in the online data supplement). Mitochondrial NADH autofluorescence was recorded at excitation/emission (340/460 nm) wavelengths. The NADH signal was calibrated by making mitochondria anoxic with N 2 to fully reduce NAD and subsequently adding O 2 and FCCP to fully oxidize NAD.
Mitochondrial iron uptake or release of bound iron in the matrix was determined by monitoring quenching of Phen Green or calcein fluorescence by chelatable iron. 11 Mitochondria were incubated with 10 mol/L Phen Green FL or 5 mol/L calcein-acetoxymethyl ester (calcein-AM) for 15 minutes at room temperature and washed, and fluorescence was measured at 490 nm excitation/520 nm emission. "Dequenching" was accomplished with 200 mol/L 1,10-phenanthroline.
Aconitase activity was determined by an increase in NADPH fluorescence after adding reaction mixture and permeabilizing inner membrane with alamethicin, as described. 12 Changes in buffer Ṅ O level released from diethylamine NONOate sodium salt (DETA-NONO) or S-nitroso-N-acetylpenicillamine were monitored electrochemically using a Ṅ O electrode (World Precision Instruments, Sarasota, Fla).
Results

Graded Hypoxia in Isolated Mitochondria
We hypothesized that when hypoxia becomes severe enough to limit electron transport rate at complex IV (ie, near the K d of cytochrome c oxidase for O 2 ), increased O 2 . production at complexes I and III may result. 3 To create a controllable level of hypoxia in a range sufficient to cause respiratory inhibition, we carefully balanced O 2 supply rate against O 2 consumption rate by isolated mitochondria in a cuvette. Figure  1A shows To document that hypoxia sufficient to depolarize ⌬⌿ m was attributable to respiratory inhibition, we also measured NADH autofluorescence ( Figure 1B ). NADH fluorescence increased significantly when O 2 was depleted to the level causing partial ⌬⌿ m depolarization. Further decreases in O 2 supply by decreasing the stirring speed increased NADH fluorescence reversibly. The maximum value of NADH fluorescence was ascertained by replacing air with N 2 , and the minimum value by adding FCCP in the presence of O 2 ( Figure 1B ). These findings demonstrate that the level of hypoxia to which isolated mitochondria are subjected can be finely regulated over a range causing graded respiratory inhibition, as manifested by partial ⌬⌿ m depolarization and increased NADH levels.
ROS Production During Hypoxia/Reoxygenation Versus Anoxia/Reoxygenation
Our next goal was to examine how graded hypoxia versus anoxia affects ROS production by isolated mitochondria. As described in detail in the online data supplement, we found that O 2 . and subsequent H 2 O 2 production in isolated mitochondria is severely underestimated by H 2 DCF oxidation rate unless Fe 2ϩ is added, so that its rapid uptake into the matrix by iron transporters generates Ȯ H radicals and/or other reactive intermediates associated with Fenton chemistry to catalyze H 2 DCF oxidation. Using this method, we compared how substrates and [O 2 ] affected mitochondrial ROS production. In Figure 2A , isolated mitochondria loaded with H 2 DCF were energized with malate/glutamate and incubated at the indicated stirring speeds to regulate O 2 supply. The amount of mitochondria and stirring speed were selected to allow a gradual decrease in buffer [O 2 ] to a few micromolar (see the online data supplement for calibration). Addition of 5 mol/L Fe 2ϩ to hypoxic mitochondria increased H 2 DCF oxidation rate, similar to normoxic mitochondria (supplemental Figure  IC ). On average, the H 2 DCF oxidation rate after 5 mol/L Fe 2ϩ was quantitatively similar for normoxic and hypoxic mitochondria ( Figure 2D ). In contrast to hypoxia, however, when 5 mol/L Fe 2ϩ was added at the same time that mitochondria were reoxygenated with compressed air, H 2 DCF oxidation rate markedly accelerated ( Figure 2B and 2D). O 2 consumption rate after reoxygenation was also decreased by 43Ϯ18% (nϭ7, PϽ0.005), indicating that the hypoxia/reoxygenation had caused persistent impairment of respiratory chain activity.
Similar findings were obtained using Amplex Red to monitor mitochondrial H 2 O 2 release into the buffer: H 2 O 2 release was inhibited by decreasing and accelerated by increasing O 2 supply, especially on reoxygenation. These changes were small compared to H 2 O 2 -dependent H 2 DCF oxidation in the matrix (supplemental Figure IVA) , probably because the site of H 2 O 2 formation is primarily in the matrix. It is also possible that, unlike liver mitochondria, catalase in the matrix of heart mitochondria obscures the ability of extramitochondrial probes such as Amplex Red to detect H 2 O 2 release, as noted previously for diazoxide-induced H 2 O 2 release. 4 On the other hand, if buffer O 2 was depleted with N 2 before adding mitochondria, addition of 5 mol/L Fe 2ϩ initiated Figure III) . With full oxygenation, H 2 DCF oxidation rate increased modestly but to a much lesser extent than in mitochondria exposed to hypoxia/reoxygenation (Figure 2D ). These findings indicate that hypoxia at a level causing partial respiratory inhibition primes mitochondria to produce excessive ROS on reoxygenation, whereas total anoxia does not. We also studied ROS production by succinate-energized mitochondria, which consume O 2 at a higher rate and can therefore deplete buffer oxygen more rapidly and completely, even in state 2. Figure 3A shows that when isolated mitochondria energized with succinate were added to buffer equilibrated with room air, they depleted O 2 much more rapidly and completely than an equivalent amount of mitochondria energized with complex I substrates (compare the rates of O 2 depletion in Figure 3A to Figures 1A, and 2A , and 2B). The final level of O 2 depletion was below the O 2 electrode sensitivity (Ͻ1 mol/L), as seen at the end of the trace in Figure 3A when room air was replaced with N 2 . At this near-anoxic level, H 2 DCF oxidation rate increased modestly. As shown in the online data supplement, these changes are attributable to H 2 DCF oxidation by thiyl radicals under anoxic conditions, which is masked in the presence of O 2 . 14 Consistent with this interpretation, the increase in H 2 DCF oxidation rate was inhibited by transient reoxygenation with an air bolus and then resumed after buffer O 2 was again depleted. Under these conditions, addition of Fe 2ϩ had little effect on H 2 DCF oxidation rate ( Figure 3A) . Moreover, when Fe 2ϩ was added at the time of reoxygenation, the increase in H 2 DCF oxidation rate was also very modest ( Figure 3B ). The average changes in H 2 DCF oxidation rate are summarized in Figure 3D . Note that compared to the same amount of identically H 2 DCF-loaded isolated mitochondria energized with complex I substrates, the increase in H 2 DCF oxidation rate in succinate-energized isolated mitochondria after reoxygenation in the presence of Fe 2ϩ was markedly reduced (compare to Figure 2D ). In all of the succinate experiments, the standard amount of mitochondria was sufficient to rapidly deplete extramitochondrial O 2 level below the sensitivity of the O 2 electrode (near-anoxia), resulting in rapid ⌬ m depolarization (data not shown). Thus, the time window during which isolated mitochondria were exposed to a level of hypoxia sufficient to partially inhibit respiratory chain activity, but not yet at the near-anoxia level associated with complete ⌬ m dissipation, was relatively short. After reoxygenation, mitochondrial O 2 consumption rate showed no signs of respiratory chain inhibition, averaging 90Ϯ3% of the prehypoxic rate.
We postulated that the lesser ROS production on reoxygenation in succinate-energized mitochondria compared to complex I-energized mitochondria might be attributable to their higher rate of O 2 consumption causing more severe O 2 depletion. To test this possibility, we added half the amount of succinate-energized mitochondria to the cuvette, to avoid severe O 2 depletion and marked ⌬ m dissipation ( Figure 3C ). The thiyl radical-related increase in H 2 DCF oxidation rate was avoided (consistent with hypoxic rather than near-anoxic conditions), and addition of Fe 2ϩ at the time of reoxygenation now markedly accelerated H 2 DCF oxidation rate ( Figure 3C and 3D) to a level comparable to complex I-energized mitochondria ( Figure 2D ), when corrected for the lesser amount of mitochondria.
Together, these findings demonstrate that hypoxia sufficient to cause partial respiratory chain inhibition results in significant Fe 2ϩ -dependent ROS production on reoxygenation, whereas exposure to an equivalent period of anoxia or near-anoxia does not have this effect.
Nitric Oxide Inhibits Fe 2؉ -H 2 O 2 -Induced H 2 DCF Oxidation After Hypoxia/Reoxygenation
Ṅ O interacts with ROS signaling and, when given at the time of reperfusion, is known to protect the heart from ischemia/ reperfusion injury (reviewed elsewhere 15 ). Ṅ O also protects cells against damaging effects of ROS, 16 and 1 possible mechanism may be inhibition of the Fenton reaction 17 caused by Ṅ O binding to Fe 2ϩ coordination sites. 18 We therefore tested the effects of Ṅ O on hypoxia-induced ROS production. In Figure 4A , complex I-energized mitochondria depleted buffer [O 2 ] to a low level, after which, they were challenged with reoxygenation and 3 Fe 2ϩ pulses, which significantly and progressively increased in H 2 DCF oxidation rate. When 10 mol/L DETA-NONO was added just before reoxygenation, however, the increase in Fe 2ϩ -dependent H 2 DCF oxidation was markedly suppressed ( Figure 4B ). The middle Ṅ O electrode trace in Figure 4B documents that DETA-NONO spontaneously released Ṅ O, which was accompanied by transient inhibition of mitochondria O 2 consumption in the upper trace. The finding that the third Fe 2ϩ pulse was delivered after buffer Ṅ O level had decreased to back to 0, but H 2 DCF oxidation rate remained low, may also indicate some suppression of ROS production by Ṅ O at the level of respiratory complexes. Figure 4C summarizes the average increase in H 2 DCF oxidation rate after the first, second, and third Fe 2ϩ additions, illustrating the marked suppression by pretreatment with DETA-NONO.
Nitric Oxide Attenuates ROS-Induced Increases in Matrix [Fe 2؉ ] and Depression of Aconitase Activity
In isolated heart, a substantial portion of ischemia/reperfusion damage is thought to be related to free radical production, catalyzed by Fe 2ϩ with open coordination sites (required for Fenton-based Ȯ H generation 19 ). 1 In calcein-loaded mitochondria exposed to hypoxia-reoxygenation, however, we did not detect significantly increased calcein quenching, as an indicator of increased matrix Fe 2ϩ . To test the hypothesis that Ṅ O inhibits the Fenton reaction 17 by binding to Fe 2ϩ coordination sites exposed by ROS, 18 we needed a more robust method to generate ROS and, so, used antimycin to increase H 2 O 2 production in energized mitochondria. Figure 5A shows that when energized calcein-loaded mitochondria were exposed to antimycin to cause a sustained increase in H 2 O 2 production (see supplemental Figure IVB ), calcein fluorescence was progressively quenched. The quenching was attributable to iron release, because it was reversed with the iron chelator phenanthroline. In Figure 5B , the Ṅ O donor DETA-NONO was added after antimycin. Whereas Ṅ O (middle trace) remained elevated, the quenching of calcein fluorescence ceased and then subsequently resumed at a slower rate after Ṅ O levels had returned to 0 and 20 as well as during ischemia/reperfusion, 21 we examined the effects of antimycin on aconitase activity. Figure 5D shows that antimycin-induced ROS significantly inhibited aconitase activity, which was attenuated by DETA-NONO. These results show that Ṅ O binding to iron can suppress the ability of endogenously generated H 2 O 2 to oxidize [4Fe-4S] clusters, release iron, and inhibit aconitase activity.
Discussion
In this study, we examined the effects of hypoxia/reoxygenation and near-anoxia/reoxygenation on ROS production by isolated mitochondria and characterized a mechanism by which Ṅ O protects against ROS-induced damage to electron transport complexes, possibly by forming dinitrosyl-dithiolato-Fe complexes in the presence of Fe 2ϩ and matrix glutathione (GSH). 22 Our major conclusions are as follows: (1) matrix ROS production is similar during hypoxia as during normoxia, despite decreased O 2 availability in the former situation; (2) following hypoxia, reoxygenation results in a marked increase in ROS production, which is associated with reduced O 2 consumption reflecting electron transport dysfunction; (3) for reoxygenation to cause a marked increase in ROS production, the degree of preceding hypoxia must be severe enough to cause partial respiratory inhibition, as reflected by modest ⌬⌿ m dissipation and increased NADH autofluorescence; (4) in contrast, following anoxia or nearanoxia severe enough to induce major ⌬⌿ m dissipation, reoxygenation does not increase ROS to nearly the same extent, and O 2 consumption returns to preanoxic levels, indicating preserved electron transport function; and (5) the increase in Fe 2ϩ -H 2 O 2 -dependent H 2 DCF oxidation after hypoxia/reoxygenation is persistently attenuated by Ṅ O, most likely as a result of Ṅ O binding to free coordination sites of iron, with subsequent inhibition of hydroxyl radical formation by the Fenton reaction.
The role of partial, in contrast to nearly complete, ⌬⌿ m dissipation in accelerating O 2 . production on reoxygenation deserves further comment. In succinate-energized mitochondria, in which O 2 . production by reverse electron transport requires a maintained proton gradient, ⌬⌿ m dissipation inhibits reverse electron transport, thereby suppressing O 2 . production. In complex I-energized mitochondria, however, reverse electron transport should not play a significant role in O 2 .
generation, 3 so full ⌬⌿ m dissipation during near-anoxia may not be the protective mechanism. It is more likely that O 2 .
production is just too severely limited by the near absence of O 2 to impair electron transport. In general, 2 conditions are required for "primary" ROS (O 2 . ) production by the respiratory chain: reduced electron transport centers (in complexes I or III) and the presence of O 2 to allow 1 electron reduction to O 2 . . A sustained O 2 supply to mitochondria with inhibited respiratory chain promotes a large increase in ROS production, which can further damage electron transport. 7 Thus, our findings are consistent with a scenario in which partial respiratory inhibition during hypoxia maintains significant ROS production in the matrix despite reduced O 2 availability, causing progressive and persistent electron transport dysfunction, such that when reoxygenation delivers O 2 in excess, ROS production markedly accelerates. In general these results support conclusions by Schumacker and colleagues 23 that were made by using cultured cardiomyocytes and novel redox-sensitive fluorescence resonance energy transfer probes. It could be argued that in our experimental setup, hypoxia is not really uniform, because isolated mitochondria are intermittently exposed to high O 2 when they swirl near the air-water interface at the top of the cuvette. However, this same process would have occurred in succinate-energized mitochondria, yet they did not show the marked increase in H 2 DCF oxidation on reoxygenation, unless the concentration of mitochondria in the cuvette was decreased. This suggests that O 2 gradients in the cuvette are unlikely to account for our findings, although we cannot exclude the possibility that ROS generation via succinatemediated reverse electron transport is inhibited because of severe ⌬⌿ m depolarization.
Our observation that anoxia or near-anoxia did not result in comparably high ROS production or persistent respiratory suppression on reoxygenation suggests that the ongoing ROS production during hypoxia plays a key role in impairing the electron transport chain. Complex I is the most sensitive to ischemia/reperfusion injury 24 and also contains at least nine Fe/S clusters that are used to transfer electrons between active sites. Interestingly, these clusters are not sensitive to exogenous H 2 O 2 , 25 suggesting that generation of O 2 . in the immediate vicinity of Fe-S clusters in complex I may be required to disrupt function during ischemia. 7 A highly localized interaction might also account for our inability to detect matrix iron release with calcein during relatively brief hypoxia/reoxygenation, in contrast to antimycin-induced ROS production into the matrix, which released iron from aconitase Fe/S clusters and inhibited aconitase activity. Regarding Fe release, antimycin may better mimic the sustained ROS production during prolonged hypoxia/reoxygenation. It is important to distinguish the putative deleterious effects of ROS after prolonged ischemia/reperfusion from the protective effects of transient mitochondrial ROS generation during ischemic and pharmacological preconditioning. 2 In the latter case, stimulation of mitochondrial ROS production, typically triggered by interventions that open mitochondrial ATP-sensitive K channels, activates downstream signaling via protein kinase pathways to protect mitochondria from injury during prolonged ischemia/reperfusion or hypoxia/ reoxygenation. 26 In triggering cardioprotection, one protective action of ROS signaling is to prevent subsequent excessive ROS production during prolonged ischemia/reperfusion. 6 The mechanisms by which ROS-mediated protein kinase signaling impacts hypoxia/reoxygenation-induced ROS production in isolated mitochondria will be an interesting area for future investigation using the approaches developed in the present study.
Effects of Ṅ O
Ṅ O administered before ischemia triggers cardioprotection by activating mito-K ATP channels via protein kinase G, stimulating mitochondrial ROS production to activate downstream cardioprotective pathways (reviewed elsewhere 26 ). However, Ṅ O administered at the time of reperfusion also protects the heart from injury. 15 28 and Fe 2ϩ /H 2 O 2 -induced oxidation was inhibited by Ṅ O, we assume that relatively little peroxynitrite was generated. In our experiments the inhibitory effect of Ṅ O on H 2 DCF oxidation rate persisted after extramitochondrial Ṅ O returned to 0 levels ( Figure 5A ), suggesting that a longer-lasting interaction, such as matrix protein S-nitrosation, may also be involved. Recent data indicates that reversible inhibition of complex I by S-nitrosation reduces ROS generation at reperfusion, with less oxidative inactivation of respiratory chain, aconitase activity, and inhibition of PTP opening. 29, 30 S-Nitrosation of mitochondrial thiols by Ṅ O also blocks thiol oxidation, inhibiting cell death induced by GSH depletion. 31 Recently, it was reported that Ṅ O can directly activate mitochondrial protein kinase C2, which inhibits permeability transition pore opening. 32 
Caveats in Using H 2 DCF As an ROS Indicator
Despite well-established experimental documentation that Fe 2ϩ or Fe 2ϩ -containing catalysts are required to measure H 2 O 2 -induced H 2 DCF oxidation, 28 recent analysis of literature suggests that in most studies, the role of the catalyst has been ignored, 33 leading to serious underestimation of matrix ROS production. However, mitochondria have a Fe 2ϩ carrier in the inner membrane, 34 making it possible to increase matrix [Fe 2ϩ ] simply by adding a known amount Fe 2ϩ . Fe 2ϩ uptake into the matrix had no direct effect on O 2 . production but promoted H 2 DCF oxidation by H 2 O 2 with greatly increased sensitivity. As shown in the online data supplement and documented recently by others, 14 in the absence of Fe 2ϩ , ROS production generates thiyl radicals from glutathione or cysteine, which do not oxidize H 2 DCF in the presence of O 2 but do in its absence. In intact cells, H 2 DCF oxidation is also promoted by cytochrome c release, independent of ROS production. 35 These technical limitations make it difficult to prove unequivocally in intact cells that mitochondria are the source of ROS, especially during hypoxia/reoxygenation and emphasize the importance of isolated mitochondria studies.
Conclusions
We have further elucidated the source of ROS production during ischemia/reperfusion by showing that in isolated mitochondria exposed to a degree of hypoxia sufficient to cause partial, but not complete, respiratory inhibition, electron transport chain is persistently depressed by ongoing matrix ROS generation. As a result, during reoxygenation, ROS production markedly accelerates, causing further suppression of electron transport, which promotes greater ROS production, etc, in a vicious cycle. Ṅ O inhibits this scenario, potentially contributing to its cardioprotective effects when administered at the time of reoxygenation in intact heart.
